NEVVI Medicare utilization intelligence
or

← back

Provider profile

HARRIS, APRIL M.D.

Ophthalmology · NPI 1316940422 · TUCSON, AZ

1
Groups
25
Codes · 2024
77,160
Disclosed services

HARRIS, APRIL is a Ophthalmology in TUCSON, AZ, a member of 1 medical group, who billed 25 distinct codes to Medicare Part B in 2024.

Groups: RASW, PC (TUCSON, AZ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

77,160
disclosed services
25
codes billed to Medicare Part B
Prior year · CY2023 58,933 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg
J2782 Injection, avacincaptad pegol, 0.1 mg
92134 Imaging of retina
67028 Injection of drug into eye
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0178 Injection, aflibercept, 1 mg
J0177 Injection, aflibercept hd, 1 mg
92014 Established patient complete exam of visual system
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
92201 Extended exam of the back part of the eye with retinal drawing
J9035 Injection, bevacizumab, 10 mg
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
92202 Extended exam of the back part of the eye with optic nerve drawing
92235 Exam of retinal blood vessels using a special camera after injection of a dye
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3490 Unclassified drugs
92012 Established patient problem focused exam of visual system
92083 Exam of visual field with extended testing
92242 Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye
92250 Photography of the retina
67145 Photocoagulation treatment to prevent detachment of retina
92004 New patient complete exam of visual system
76512 2d ultrasound scan of eye tissue and structures
76510 1d and 2d ultrasound scan of eye tissue and structures
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.